QTMeds

Drug Database Monograph

BEOVU 120 mg/ml

PENDING REVIEW

Active Ingredient: BROLUCIZUMAB

QTc Interval Status:

neutral

Clinical Description (Database Summary)

Scientific Sources / References

Analyse RCP (Automatique), id : 65607585

← Back to Prescription Analyzer